Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:NVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVSNovartis$126.94+0.1%$119.37$96.06▼$128.03$268.24B0.621.55 million shs1.34 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVSNovartis0.00%+2.21%+8.12%+12.57%+7.92%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNVSNovartis1.891 of 5 stars1.03.02.50.03.50.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVSNovartis 2.09Hold$123.50-2.71% DownsideCurrent Analyst Ratings BreakdownLatest NVS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025NVSNovartisMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$123.00(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVSNovartis$50.32B5.33$10.69 per share11.87$19.91 per share6.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVSNovartis$11.94B$6.8718.4814.411.7825.64%41.08%16.83%11/4/2025 (Estimated)Latest NVS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/17/2025Q2 2025NVSNovartis$2.38$2.42+$0.04$2.06$13.94 billion$14.05 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNVSNovartis$2.602.05%N/A37.85%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVSNovartis0.530.820.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVSNovartis13.12%Insider OwnershipCompanyInsider OwnershipNVSNovartis0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVSNovartis75,8832.11 billion2.11 billionOptionableNVS HeadlinesRecent News About These CompaniesRep. Lisa C. McClain Purchases Shares of Novartis AG (NYSE:NVS)1 hour ago | americanbankingnews.comSEC Hits Ex-Chinook Director With Novartis Insider Trade ClaimsAugust 23 at 7:43 PM | news.bloomberglaw.comNNovartis AG $NVS Stock Position Raised by Martin Investment Management LLCAugust 23 at 7:59 AM | marketbeat.comNorthern Trust Corp Purchases 47,690 Shares of Novartis AG $NVSAugust 23 at 5:24 AM | marketbeat.comNovartis AG $NVS Shares Sold by American Century Companies Inc.August 23 at 4:43 AM | marketbeat.comInvesco Ltd. Lowers Stock Holdings in Novartis AG $NVSAugust 23 at 4:16 AM | marketbeat.comNovartis AG $NVS Position Increased by Osterweis Capital Management Inc.August 22 at 7:13 AM | marketbeat.comKepler Capital Reaffirms Their Buy Rating on Novartis AG (NOVN)August 22 at 6:36 AM | theglobeandmail.comNovartis price target raised to CHF 120 from CHF 115 at Deutsche BankAugust 22 at 6:36 AM | msn.comNovartis AG $NVS Holdings Decreased by Wellington Management Group LLPAugust 22 at 5:05 AM | marketbeat.comNovartis (NYSE:NVS) Sets New 1-Year High - Time to Buy?August 21 at 11:43 AM | marketbeat.comNovartis AG $NVS Shares Bought by Brooklyn Investment GroupAugust 21 at 4:59 AM | marketbeat.comRaymond James Financial Inc. Sells 11,448 Shares of Novartis AG $NVSAugust 21 at 4:42 AM | marketbeat.comNovartis AG $NVS Stock Position Reduced by Cambiar Investors LLCAugust 20, 2025 | marketbeat.comCorient IA LLC Buys Shares of 5,000 Novartis AG (NYSE:NVS)August 19, 2025 | marketbeat.comCresset Asset Management LLC Has $13.13 Million Stake in Novartis AG (NYSE:NVS)August 19, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Purchased by Kovitz Investment Group Partners LLCAugust 19, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by Boston PartnersAugust 19, 2025 | marketbeat.comEthic Inc. Trims Position in Novartis AG (NYSE:NVS)August 18, 2025 | marketbeat.comVirtu Financial LLC Decreases Position in Novartis AG (NYSE:NVS)August 18, 2025 | marketbeat.comBenjamin Edwards Inc. Sells 32,839 Shares of Novartis AG (NYSE:NVS)August 18, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNVS Company DescriptionsNovartis NYSE:NVS$126.94 +0.12 (+0.10%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$127.34 +0.40 (+0.32%) As of 08/22/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access